4,166 research outputs found

    The world's first malaria vaccine – promising clinical results

    Get PDF
    Dudek Iga, Czarnota Jakub, Hajduga Danuta, Dobrzyński Michał, Marzęda Magdalena. The world's first malaria vaccine – promising clinical results. Journal of Education, Health and Sport. 2019;9(8):912-919. eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.3408433 http://ojs.ukw.edu.pl/index.php/johs/article/view/7452 The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019. © The Authors 2019; This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike. (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 05.07.2019. Revised: 25.07.2019. Accepted: 14.09.2019. The world's first malaria vaccine – promising clinical results Iga Dudek, Jakub Czarnota, Danuta Hajduga, Michał Dobrzyński, Magdalena Marzęda Student Research Circle at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin Supervisor: dr n. med. Halina Piecewicz-Szczęsna Corresponding author: Halina Piecewicz-Szczęsna, e-mail: [email protected] ORCID ID: Iga Dudek: orcid.org/0000-0002-8101-074X; [email protected] Jakub Czarnota: orcid.org/0000-0003-2783-0349; [email protected] Danuta Hajduga: orcid.org/0000-0002-7018-340X; [email protected] Michał Dobrzyński: orcid.org/0000-0002-1416-6568; [email protected] Magdalena Marzęda: orcid.org/0000-0003-4397-5214; [email protected] Abstract Work on the malaria vaccine has been going on since the early 20st century. The RTS,S/AS01 (Mosquirix) vaccine is the first and only in the world that has shown action against Plasmodium falciparum, a germ that contributes to the highest number of deaths from malaria. After passing the three phases of clinical tests positively, the fourth phase was launched in 2019 - the MVIP program (The Malaria Vaccine Implementation Program). It covers three African countries: Kenya, Ghana and Modawi. Around 360,000 children are expected to receive the vaccine from these countries annually. The third phase of Mosquirix vaccine testing lasted five years (2009-2014) and was based on the extraction of 15 459 children and infants from seven African countries, followed by the administration of four doses of each medicine. In four years, among children aged 5-17 months who received 4 doses of Mosquirix, 4 out of 10 (39%) managed to prevent the development of malaria. The number of hospitalizations for malaria and severe anemia, which is one of the consequences of this disease, has also decreased significantly. In the fourth phase of the study, the role of the vaccine in reducing the number of deaths in children and its safety will be assessed in the context of routine, global use. Data from the MVIP program will include WHO recommendations on the wider use of the vaccine. Keywords: malaria, the MVIP programme, vaccin

    Postpamięciowy dyskurs w literaturze dla dzieci i młodzieży. Małgorzata Wójcik-Dudek. “W(y)czytać Zagładę. Praktyki postpamięci w polskiej literaturze XXI wieku dla dzieci i młodzieży”. Wydawnictwo Uniwersytetu Śląskiego, Katowice 2016, ss. 332

    Get PDF
    Recenzja książki Małgorzaty Wójcik-Dudek, “W(y)czytać Zagładę. Praktyki postpamięci w polskiej literaturze XXI wieku dla dzieci i młodzieży”. Wydawnictwo Uniwersytetu Śląskiego, Katowice 2016

    Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time

    Get PDF
    The measurement of blood clotting time is important in a range of clinical applications such as assessing coagulation disorders and controlling the effect of various anticoagulant drug therapies. Clotting time tests essentially measure the onset of clot formation which results from the formation of fibrin fibers in the blood sample. However, such assays are inherently imprecise due to the highly variable nature of the clot formation process and the sample matrix. This work describes a clotting time measurement assay which uses a fluorescent probe to very precisely detect the onset of fibrin clot formation. It uses a microstructured surface which enhances the formation of multiple localized clot loci and which results in the abrupt redistribution of the fluorescent label at the onset of clot formation in both whole blood and plasma. This methodology was applied to the development of an activated partial thromboplastin time (aPTT) test in a lateral flow microfluidic platform and used to monitor the effect of heparin dosage where it showed linearity from 0 to 2 U/mL in spiked plasma samples (R-2=0.996, n = 3), correlation against gold standard coagulometry of 0.9986, and correlation against standard hospital aPTT in 32 patient samples of 0.78.Original Publication: Magdalena M Dudek, Nigel Kent, Kerstin Gustafsson, Tomas Lindahl and Anthony J Killard, Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time, 2011, ANALYTICAL CHEMISTRY, (83), 1, 319-328. http://dx.doi.org/10.1021/ac102436v Copyright: ACS American Chemical Society http://pubs.acs.org

    Collective Improvisation: The Practice and Vision of Ingemar Lindh

    Get PDF
    Ingemar Lindh's research on the principles of collective improvisation and performance conceived as process announce an important development in the 20th-century tradition of the actor's work. After early studies with Étienne Decroux and working collaborations with Jerzy Grotowski, Eugenio Barba, and Yves Lebreton, Lindh founded the first laboratory theatre in Sweden in 1971, the Institutet för Scenkonst. His practice of collective improvisation is viewed in light of postdramatic concerns such as its resistance to fixed scores, directorial montage, and choreography as an organizing principle

    Zn(II) and Cu(II) binding sites of Calcitermin, an antimicrobial peptide found in human airways

    No full text
    Antimicrobial peptides (AMPs) are evolutionarily conserved molecules with antimicrobial and/or immunomodulatory properties. Almost all antimicrobial peptides are cationic and amphipathic. AMPs are widely distributed in many tissues and cells and are potentially present in any species of invertebrate, plant and animal. They act as mediators of innate host defense, being able to target Gram-positive and Gram-negative bacteria as well as fungi and some enveloped viruses. Therefore, they represent a fertile ground for the design of novel therapeutics for the treatment of antibiotic-resistant infections and severe sepsis.[1] Mediators of innate host defense are also found in mucosal secretions of the respiratory tract and include substances, like antimicrobial proteins and (poly)peptides, that can sequester metal nutrients, such as Zn(II), Cu(II), Ni(II), Ca(II), etc.[2-3] Among several uncharacterized molecules that contribute to the overall antimicrobial activity of human nasal fluid, a 15-residue antimicrobial peptide named Calcitermin has been identified.[4] Its sequence (VAIALKAAHYHTHKE) exactly corresponds to the C-terminal domain of Calgranulin C, a calcium-binding pro-inflammatory protein of the S100 family. Several studies have reported that cleavage fragments of parent proteins have potent antimicrobial activity (e.g. buforin I,[5] lactoferricin,[6] KDAMP,[7] vasostatin-1[8]). While Calcitermin does not express, in vitro, any antimicrobial activity in phosphate buffer at pH 7.4, under more acidic conditions (pH 5.4) – which are quite common in inflammatory fluids – it was active against E. coli, P. aeruginosa and C. albicans. Furthermore, it was demonstrated that the presence of micromolar concentrations of Zn(II) enhances its antimicrobial activity against E. coli and L. monocytogenes.[4] Calcitermin contains a putative metal-binding domain with three alternated histidine residues (His9, His11 and His13) and the free terminal amino group. In addition, it has the potential to adopt a helical conformation in membranes. The above results prompted us to deeply investigate the complex-formation equilibria of Calcitermin with Zn(II) and Cu(II), two endogenic and competing metal ions. The unprotected peptide VAIALKAAHYHTHKE has been considered, along with its three mutants, in which each His residue is replaced with one alanine (VAIALKAAAYHTHKE, VAIALKAAHYATHKE, VAIALKAAHYHTAKE). The characterization of the complexes has been achieved by means of mass spectrometry, potentiometry, UV-Vis spectrophotometry, circular dichroism (CD) and nuclear magnetic resonance (NMR). Biological tests were also performed. The comparison among the behaviors of the different analogues helps to shed light on the role played by each His residue in metal coordination geometry and complex stability also in the view of its antimicrobial activity. The preliminary results show that all the investigated peptides are efficient ligands for the considered metal ions and are able to form mono-nuclear complexes where the histidine residues are by far the first metal anchor (Fig.1). References: [1] R. E. W. Hancock, H.-G. Sahl, Nat. Biotechnol. 2006, 24, 1551. [2] K. A. Brogden, Nat. Rev. Microbiol. 2005, 3, 238. [3] T. Ganz, Integr. Comp. Biol. 2003, 43, 300-304. [4] A. M. Cole, Y.-H. Kim, S. Tahk, T. Hong, P. Weis, A. J. Waring, T. Ganz, FEBS Lett. 2001, 504, 5-10. [5] I. Minn, H. S. Kim, S. C. Kim, Biochim. Biophys. Acta - Molecular Basis of Disease 1998, 1407, 31-39. [6] K. Yamauchi, M. Tomita, T. J. Giehl, R. T. Ellison, 3rd, Infect. Immun. 1993, 61, 719-728. [7] C. Tam, J. J. Mun, D. J. Evans, S. M. J. Fleiszig, J. Clin. Investig. 2012, 122, 3665-3677. [8] K. Lugardon, R. Raffner, Y. Goumon, A. Corti, A. Delmas, P. Bulet, D. Aunis, M. H. Metz-Boutigue, J. Biol. Chem. 2000, 275, 10745-10753

    From electrophilic to stereospecific SN2 alpha-functionalization reactions of acyclic carboxylic acid derivatives

    No full text
    Author Magdalena Piringer, BScMasterarbeit Universität Linz 202

    Conversion and Artistic Creation of Magdalena V.

    No full text
    This Bachelor thesis Conversion and Artistic Creation of Magdalena V. deals with the change of artistic expression of the Czech graphic artist Magdalena V., in a close connection to her religious conversion to the Catholic faith. The first part summarizes the theoretical knowledge of the psychology of religion. It introduces basic definitions and concepts of religion in relation to a religious conversion. In the second part, the author deals with the psychological analysis of Magdalena V.'s typical work through her life, which is supported by numerous photographs. Using the approach of rožnovská school, the author attempts to interpret this artwork on a hypothetical level, focusing on the M.V.'s life and artistic paralel before and after her conversion. The author draws on Magdalena V.'s testimonies about her life which bring light on the intention and context in her art. Related to the author's identification with Magdalena V.'s work, which later became apparent, this paper evolved further into identifying these moments and thus the potential risks inherent in author's own therapeutic work

    The Development of Sculpture in the Quito School

    No full text
    Magdalena Gallegos de Donoso, Ecuadorian anthropologist and art historian, author of over fifty exhibition catalogues, Director of the Central Bank of Ecuador Museums
    corecore